CD8A and neoplasm: Most studies assessing CD3+ or CD8+ T cells in the tumor epithelium or invasive margin found a trend towards or a significantly longer OS or disease-free survival (DFS) in patients with high T cell infiltration [9,16,18,19,21,22,25,26].